InvestSMART

Osteopore Limited (ASX: OSX) - Share Price

- Current share price for OSX : $0.003

Osteopore Limited (OSX) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a global medical technology Company that commercialises products designed to enable natural bone healing across multiple therapeutic areas. The Company's patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.

OSX General Information +

ASX Code OSX
Website N/A
Industry/Sector Health Care Supplies
Market Cap ($M) 2
OSX Share Price $0.003
Day High $0.003
Day Low $0.003
Last Close $0.003
OSX Share Price Movement - ( No change )
Prices as at 16:40, 13 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Osteopore Limited (OSX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Osteopore Limited (OSX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Osteopore Limited (OSX) price-sensitive announcements

OSX - Activities Report September 2026 and Appendix 4C
Osteopore Limited (ASX: OSX) reported its Q3 CY26 Activities Report and Appendix 4C for th
Osteopore Limited (OSX)
30 Oct 2026 | 6:05 PM
OSX - Half Yearly Report and Accounts
Osteopore Limited’s consolidated half-year report for the six months ended 30 June 2026 sh
Osteopore Limited (OSX)
31 Aug 2026 | 7:22 PM
OSX - OSX strikes orthopaedic deal for 5 Middle East countries
Osteopore Limited, an Australian-Singaporean regenerative medicine company, announced a si
Osteopore Limited (OSX)
6 Aug 2026 | 8:45 AM
OSX - Activities Report June 2026 and Appendix 4C
Osteopore Limited released its quarterly results and Appendix 4C Quarterly Cash Flow Repor
Osteopore Limited (OSX)
31 Jul 2026 | 9:01 AM

Osteopore Limited (OSX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Osteopore Limited (OSX)
ORDINARY FULLY PAID
 Health Care $2 OSX focuses on Ortho line in Singapore via direct selling 2 Nov 2026 9:21AM $0.004 $0.003 fallen by 25%
Osteopore Limited (OSX)
ORDINARY FULLY PAID
 Health Care $2 Activities Report September 2026 and Appendix 4C 30 Oct 2026 6:05PM $0.004 $0.003 fallen by 25%
Osteopore Limited (OSX)
ORDINARY FULLY PAID
 Health Care $2 Resignation and appointment of Company Secretary 2 Oct 2026 3:57PM $0.004 $0.003 fallen by 25%
Osteopore Limited (OSX)
ORDINARY FULLY PAID
 Health Care $2 OSX secures market access to Thailand orthopaedic market 9 Sep 2026 8:33AM $0.005 $0.003 fallen by 40%
Osteopore Limited (OSX)
ORDINARY FULLY PAID
 Health Care $2 Half Yearly Report and Accounts 31 Aug 2026 7:22PM $0.005 $0.003 fallen by 33.33%
Osteopore Limited (OSX)
ORDINARY FULLY PAID
 Health Care $2 OSX strikes orthopaedic deal for 5 Middle East countries 6 Aug 2026 8:45AM $0.005 $0.003 fallen by 33.33%

OSX Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$3.63 -$1.90 -54.90% 0.00 0.00 0.00% 0.0%
2024A -$3.35 -$4.30 -49.20% 0.00 0.00 0.00% 0.0%
2023A -$4.87 -$8.40 -6.20% 0.00 0.00 0.00% 0.0%

OSX Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Ansell Limited (ANN) $6,525M 0.1231 -0.0793 0.1002 21.6400 23.5027 21.3616 2.13% 1.79% 1.98%
Nanosonics Limited (NAN) $832M -0.1375 -0.3501 0.6933 48.1802 74.1333 43.7795 0.00% 0.00% 0.00%
Osteopore Limited (OSX) $2M -0.5491 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Polynovo Limited (PNV) $625M -0.0899 -0.4186 1.0000 52.6163 90.5000 45.2500 0.00% 0.00% 0.00%

OSX Directors

Name Position Start Date
Dr Yujing Lim Chief Executive Officer, Executive Director 24 Sep 2024
Mr Mark Kei Wei Leong Executive Chairman, Executive Director 1 Aug 2021
Professor Swee Hin Teoh Non-Executive Director 24 Jun 2019
Hon Michael Keenan Non-Executive Director 18 Jul 2023

Osteopore Limited (OSX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
8 May 2024 LEONG, Mark Issued Direct Shares 125,000 $0.029 $3,625.000
8 May 2024 TEOH, Swee Hin Issued Indirect Shares 584,897 $0.029 $16,962.000
4 Jul 2023 LEONG, Mark Sell Direct Shares 162,500 $0.083 $13,501.800

See all changes in directors' interest & trades for Osteopore Limited (OSX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

OSX Management

Name Position
Harry Miller Company Secretary

OSX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Osteopore Limited (OSX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
89,196,511 (15.86%) Citicorp Nominees Pty Ltd
70,739,752 (12.58%) BNP Paribas Nominees Pty Ltd

OSX Calendar of Events

Date Event
30 August 2027 Report (Interim)
30 March 2027 Report (Annual)
26 February 2027 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.